TXTian Xia

Tian Xia

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Tian Xia has a total of 18 co-authors. Here are the top co-authors by number of shared publications:

  • Hong-Bing Shu

    Department of Infectious Diseases, Medical Research Institute, Taikang Center for Life and Medical Sciences, State Key Laboratory for Virology and Biosafety, Zhongnan Hospital of Wuhan University, Wuhan University

    3 shared publications
  • Xin Wu

    State Key Laboratory of Animal Disease Control and Prevention, College of Veterinary Medicine, Lanzhou University, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences

    3 shared publications
  • Jin-Ke Yang

    State Key Laboratory of Animal Disease Control and Prevention, College of Veterinary Medicine, Lanzhou University, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Lanzhou 730046, China; Gansu Province Research Center for Basic Disciplines of Pathogen Biology, Lanzhou 730046, China

    2 shared publications
  • Mi Li

    Department of Infectious Diseases, Medical Research Institute, Taikang Center for Life and Medical Sciences, Zhongnan Hospital of Wuhan University, Wuhan University, Wuhan, China

    2 shared publications
  • Yang Yang

    State Key Laboratory of Animal Disease Control and Prevention, College of Veterinary Medicine, Lanzhou University, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences

    2 shared publications
  • Yuan-Pan Hou

    State Key Laboratory of Animal Disease Control and Prevention, College of Veterinary Medicine, Lanzhou University, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Lanzhou 730046, China; Gansu Province Research Center for Basic Disciplines of Pathogen Biology, Lanzhou 730046, China

    2 shared publications

Latest Publications

  • Open Access

    The lumpy skin disease virus protein LSDV003 regulates MHC-I trafficking and surface expression

    by Yang Yang, Lu-Yao Gao, Ai-Min Guo, Huai-Jie Jia, Mi Li, Xin Wu, Hong-Bing Shu, Tian Xia

    Lumpy skin disease (LSD) is a severe transboundary disease of cattle caused by lumpy skin disease virus (LSDV), which is highly transmissible and responsible for substantial economic losses worldwide. Although cellular immune responses are critical for controlling poxvirus infections, the viral strategies used by LSDV to evade cytotoxic T-cell immunity remain poorly understood. In this study, we demonstrate that LSDV infection markedly downregulates major histocompatibility complex class I (MHC-I) surface expression in host cells. Screening of LSDV-encoded proteins identified LSDV003 as a key viral factor responsible for MHC-I downregulation. Mechanistically, LSDV003 interacts with both the MHC-I heavy chain and β2-microglobulin and mediates endoplasmic reticulum (ER) retention of MHC-I via a C-terminal HNEL motif, thereby preventing its transport to the cell surface. Mutational analyses demonstrated that disruption of the HNEL motif impaired the ability of LSDV003 to alter MHC-I localization and surface expression. Furthermore, an LSDV003-deficient virus exhibited a markedly reduced capacity to suppress MHC-I surface expression. Collectively, these findings identify LSDV003 as a viral regulator of MHC-I trafficking and reveal a mechanism by which LSDV modulates host immune recognition. IMPORTANCE: Lumpy skin disease is a highly contagious viral disease of cattle that has spread rapidly across Afro-Eurasia and causes major economic losses. However, the mechanisms used by lumpy skin disease virus to evade host immune defenses remain incompletely understood. In this study, we identify a previously unrecognized lumpy skin disease virus protein, LSDV003, that reduces the surface expression of major histocompatibility complex class I molecules in infected cells. We found that LSDV003 prevents these molecules from leaving the endoplasmic reticulum by using a C-terminal retention motif, thereby altering their normal intracellular trafficking. An LSDV003-deficient virus showed a reduced ability to suppress major histocompatibility complex class I surface expression during infection. These findings reveal an important immune evasion strategy used by lumpy skin disease virus and highlight LSDV003 as a potential target for improved vaccines and antiviral approaches to control this economically important disease.

  • Open Access

    Brucella Omp25 activates the unfolded protein response to promote intracellular proliferation and inflammation

    by Jin-Ke Yang, Shuang Huang, Yuan-Pan Hou, Hui-Fei Yuan, Yue Wang, Mi Li, Li-Bo Cao, Tian Xia, Hong-Bing Shu, Xin Wu


  • Open Access

    Optimizing antigen selection for the development of tuberculosis vaccines

    by Yang Yang, Yi-Zhen Chen, Tian Xia


  • Open Access

    Regulation of TRIF-mediated innate immune response by K27-linked polyubiquitination and deubiquitination

    by Xin Wu, Caoqi Lei, Tian Xia, Xuan Zhong, Qing Yang, Hong-Bing Shu

    TIR domain-containing adaptor inducing interferon-β (TRIF) is an essential adaptor protein required for innate immune responses mediated by Toll-like receptor (TLR) 3- and TLR4. Here we identify USP19 as a negative regulator of TLR3/4-mediated signaling. USP19 deficiency increases the production of type I interferons (IFN) and proinflammatory cytokines induced by poly(I:C) or LPS in vitro and in vivo. Usp19-/- mice have more serious inflammation after poly(I:C) or LPS treatment, and are more susceptible to inflammatory damages and death following Salmonella typhimurium infection. Mechanistically, USP19 interacts with TRIF and catalyzes the removal of TRIF K27-linked polyubiquitin moieties, thereby impairing the recruitment of TRIF to TLR3/4. In addition, the RING E3 ubiquitin ligase complex Cullin-3-Rbx1-KCTD10 catalyzes K27-linked polyubiquitination of TRIF at K523, and deficiency of this complex inhibits TLR3/4-mediated innate immune signaling. Our findings thus reveal TRIF K27-linked polyubiquitination and deubiquitination as a critical regulatory mechanism of TLR3/4-mediated innate immune responses.